Intravenous immunoglobulin prophylaxis for recurrent Stevens-Johnson syndrome.
Human intravenous immunoglobulin has been described as a treatment for patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. We describe the prophylactic use of intravenous immunoglobulin to prevent Stevens-Johnson syndrome in a woman undergoing cardiac catheterization with a previous history of four episodes of Stevens-Johnson after receiving intravenous contrast dye.
Hebert
Adelaide A
AA
Department of Dermatology, The University of Texas Health Science Center, Houston, Texas 77030, USA. Adelaide.A.Herbert@uth.tmc.edu
Bogle
Melissa A
MA
D000368:Aged; D006328:Cardiac Catheterization; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D012008:Recurrence; D013262:Stevens-Johnson Syndrome / Q000473:pathology / Q000517:prevention & control*; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous